Chronic consumption of a western diet induces robust glial activation in aging mice and in a mouse model of Alzheimer's disease

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Graham, Leah C ^a,b   Harder, Jeffrey M ^a   Soto, Ileana ^a   De Vries, Wilhelmine N ^a,c   John, Simon W M ^a,b,c,d   Howell, Gareth R ^a,b  

^a JACKSON LABORATORY   (United States)

^b TUFTS UNIVERSITY   (United States)

^c HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^d TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADVERSE EFFECTS; AGING; ALZHEIMER DISEASE; ANIMAL; DISEASE MODEL; GENETICS; GLIOSIS; METABOLISM; MICROGLIA; MOUSE; PATHOLOGY; TRANSGENIC MOUSE; WESTERN DIET;

AGING; ALZHEIMER DISEASE; ANIMALS; DIET, WESTERN; DISEASE MODELS, ANIMAL; GLIOSIS; MICE; MICE, TRANSGENIC; MICROGLIA;

EID: 84958752230     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep21568     Document Type: Article

References (64)

1. Braak, H. & Braak, E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82, 239-259, doi: 10.1007/BF00308809 (1991).
2. Bero, A. W. et al. Neuronal activity regulates the regional vulnerability to amyloid-beta deposition. Nat Neurosci 14, 750-756, doi: 10.1038/nn.2801 (2011).
3. Hooli, B. V. et al. Role of common and rare APP DNA sequence variants in Alzheimer disease. Neurology 78, 1250-1257, doi: 10.1212/WNL.0b013e3182515972 (2012).
4. Thinakaran, G. et al. Stable Association of Presenilin Derivatives and Absence of Presenilin Interactions with APP. Neurobiology of Disease 4, 438-453, doi: http://dx.doi.org/10.1006/nbdi.1998.0171 (1998).
5. Genin, E. et al. APOE and Alzheimer disease: a major gene with semi-dominant inheritance. Mol Psychiatry 16, 903-907, doi: http://www.nature.com/mp/journal/v16/n9/suppinfo/mp201152s1.html (2011).
6. Harold, D. et al. Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease. Nat Genet 41, 1088-1093, doi: 10.1038/ng.440 (2009).
7. Lambert, J.-C. et al. Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nat Genet 45, 1452-1458, doi: 10.1038/ng.2802 http://www.nature.com/ng/journal/v45/n12/abs/ng.2802.html - supplementary-information (2013).
8. Ogden, C. L., Carroll, M. D., Kit, B. K. & Flegal, K. M. PRevalence of childhood and adult obesity in the united states, 2011-2012. JAMA 311, 806-814, doi: 10.1001/jama.2014.732 (2014).
9. Kivipelto, M., Ngandu, T., Fratiglioni, L. et al. OBesity and vascular risk factors at midlife and the risk of dementia and alzheimer disease. Archives of Neurology 62, 1556-1560, doi: 10.1001/archneur.62.10.1556 (2005).
10. Qizilbash, N. et al. BMI and risk of dementia in two million people over two decades: a retrospective cohort study. The Lancet Diabetes & Endocrinology, doi: 10.1016/S2213-8587(15)00033-9.
11. Cordain, L. et al. Origins and evolution of the Western diet: health implications for the 21st century. The American Journal of Clinical Nutrition 81, 341-354 (2005).
12. Allison, D. B., Fontaine, K. R., Manson, J. E., Stevens, J. & VanItallie, T. B. Annual deaths attributable to obesity in the United States. Jama 282, 1530-1538 (1999).
13. Hedley, A. A. et al. Prevalence of overweight and obesity among US children, adolescents, and adults, 1999-2002. Jama 291, 2847-2850 (2004).
14. Popkin, B. M., Adair, L. S. & Ng, S. W. Global nutrition transition and the pandemic of obesity in developing countries. Nutrition reviews 70, 3-21 (2012).
15. WHO, J. & Consultation, F. E. Diet, nutrition and the prevention of chronic diseases. WHO technical report series, 1-60 (2003).
16. Association, A. D. Evidence-based nutrition principles and recommendations for the treatment and prevention of diabetes and related complications. Clinical Diabetes 20, 53-64 (2002).
17. Pistell, P. J. et al. Cognitive impairment following high fat diet consumption is associated with brain inflammation. Journal of neuroimmunology 219, 25-32, doi: 10.1016/j.jneuroim.2009.11.010 (2010).
18. Oksman, M. et al. Impact of different saturated fatty acid, polyunsaturated fatty acid and cholesterol containing diets on beta-amyloid accumulation in APP/PS1 transgenic mice. Neurobiol Dis 23, 563-572, doi: 10.1016/j.nbd.2006.04.013 (2006).
19. Valladolid-Acebes, I. et al. High-fat diets impair spatial learning in the radial-arm maze in mice. Neurobiology of learning and memory 95, 80-85 (2011).
20. Knight, E. M., Martins, I. V. A., Gümüsgöz, S., Allan, S. M. & Lawrence, C. B. High-fat diet-induced memory impairment in triple-transgenic Alzheimer's disease (3xTgAD) mice is independent of changes in amyloid and tau pathology(). Neurobiology of Aging 35, 1821-1832, doi: 10.1016/j.neurobiolaging.2014.02.010 (2014).
21. Shie, F.-S., Jin, L.-W., Cook, D. G., Leverenz, J. B. & LeBoeuf, R. C. Diet-induced hypercholesterolemia enhances brain Aβ accumulation in transgenic mice. Neuroreport 13, 455-459 (2002).
22. Julien, C. et al. High-fat diet aggravates amyloid-beta and tau pathologies in the 3xTg-AD mouse model. Neurobiology of aging 31, 1516-1531 (2010).
23. Campbell II, T. M. The China study: the most comprehensive study of nutrition ever conducted and the startling implications for diet, weight loss and long-term health. (BenBella Books, Inc., 2004).
24. Naderali, E. K., Ratcliffe, S. H. & Dale, M. C. Review: Obesity and Alzheimer's Disease: A Link Between Body Weight and Cognitive Function in Old Age. American Journal of Alzheimer's Disease and Other Dementias 24, 445-449, doi: 10.1177/1533317509348208 (2009).
25. Heneka, M., O'Banion, M. K., Terwel, D. & Kummer, M. Neuroinflammatory processes in Alzheimer's disease. J Neural Transm 117, 919-947, doi: 10.1007/s00702-010-0438-z (2010).
26. Ankeny, D. P. & Popovich, P. G. Mechanisms and implications of adaptive immune responses after traumatic spinal cord injury. Neuroscience 158, 1112-1121, doi: http://dx.doi.org/10.1016/j.neuroscience.2008.07.001 (2009).
27. Nagareddy, Prabhakara R. et al. Adipose Tissue Macrophages Promote Myelopoiesis and Monocytosis in Obesity. Cell Metabolism 19, 821-835, doi: http://dx.doi.org/10.1016/j.cmet.2014.03.029 (2014).
28. Levinson, R. Obesity: Recruiting inflammatory cells to fat. Nature medicine 20, 594-594, doi: 10.1038/nm.3603 (2014).
29. Jay, T. R. et al. TREM2 deficiency eliminates TREM2+ inflammatory macrophages and ameliorates pathology in Alzheimer's disease mouse models. J Exp Med 212, 287-295, doi: 10.1084/jem.20142322 (2015).
30. Jonsson, T. et al. Variant of TREM2 associated with the risk of Alzheimer's disease. New England Journal of Medicine 368, 107-116 (2013).
31. Perry, V. H., Cunningham, C. & Holmes, C. Systemic infections and inflammation affect chronic neurodegeneration. Nature Reviews Immunology 7, 161-167 (2007).
32. Frank, S. et al. TREM2 is upregulated in amyloid plaque-associated microglia in aged APP23 transgenic mice. Glia 56, 1438-1447, doi: 10.1002/glia.20710 (2008).
33. Salminen, A., Ojala, J., Kauppinen, A., Kaarniranta, K. & Suuronen, T. Inflammation in Alzheimer's disease: Amyloid-β oligomers trigger innate immunity defence via pattern recognition receptors. Progress in Neurobiology 87, 181-194, doi: http://dx.doi.org/10.1016/j.pneurobio.2009.01.001 (2009).
34. Jankowsky, J. L. et al. Mutant presenilins specifically elevate the levels of the 42 residue beta-amyloid peptide in vivo: evidence for augmentation of a 42-specific gamma-secretase. Human Molecular Genetics 13, 159-170, doi: 10.1093/hmg/ddh019 (2004).
35. Jankowsky, J. L. et al. Co-expression of multiple transgenes in mouse CNS: a comparison of strategies. Biomolecular Engineering 17, 157-165, doi: http://dx.doi.org/10.1016/S1389-0344(01)00067-3 (2001).
36. Jay, T. R. et al. TREM2 deficiency eliminates TREM2+ inflammatory macrophages and ameliorates pathology in Alzheimer's disease mouse models. The Journal of experimental medicine 212, 287-295 (2015).
37. Clee, S. M. & Attie, A. D. The genetic landscape of type 2 diabetes in mice. Endocrine reviews 28, 48-83, doi: 10.1210/er.2006-0035 (2007).
38. Elias, M. F., Elias, P. K., Sullivan, L. M., Wolf, P. A. & D'Agostino, R. B. Obesity, diabetes and cognitive deficit: The Framingham Heart Study. Neurobiology of Aging 26, 11-16, doi: http://dx.doi.org/10.1016/j.neurobiolaging.2005.08.019 (2005).
39. Sjögren, K. et al. Body Fat Content Can Be Predicted In Vivo in Mice Using a Modified Dual-Energy X-Ray Absorptiometry Technique. The Journal of Nutrition 131, 2963-2966 (2001).
40. Jackson, H., Soto, I., Graham, L., Carter, G. & Howell, G. Clustering of transcriptional profiles identifies changes to insulin signaling as an early event in a mouse model of Alzheimer's disease. BMC Genomics 14, 831 (2013).
41. Burgess, B. L. et al. Elevated plasma triglyceride levels precede amyloid deposition in Alzheimer's disease mouse models with abundant Aβ in plasma. Neurobiology of Disease 24, 114-127, doi: http://dx.doi.org/10.1016/j.nbd.2006.06.007 (2006).
42. Richner, M., Bach, G. & West, M. J. Over expression of amyloid beta-protein reduces the number of neurons in the striatum of APPswe/PS1ΔE9. Brain Research 1266, 87-92, doi: http://dx.doi.org/10.1016/j.brainres.2009.02.025 (2009).
43. Rupp, N. J., Wegenast-Braun, B. M., Radde, R., Calhoun, M. E. & Jucker, M. Early onset amyloid lesions lead to severe neuritic abnormalities and local, but not global neuron loss in APPPS1 transgenic mice. Neurobiology of Aging 32, 2324.e2321-2324.e2326, doi: http://dx.doi.org/10.1016/j.neurobiolaging.2010.08.014 (2011).
44. Blanchard, V. et al. Time sequence of maturation of dystrophic neurites associated with Aβ deposits in APP/PS1 transgenic mice. Experimental Neurology 184, 247-263, doi: http://dx.doi.org/10.1016/S0014-4886(03)00252-8 (2003).
45. Wirths, O., Weis, J., Szczygielski, J., Multhaup, G. & Bayer, T. A. Axonopathy in an APP/PS1 transgenic mouse model of Alzheimer's disease. Acta Neuropathol 111, 312-319 (2006).
46. Guillot-Sestier, M.-V. et al. Il10 Deficiency Rebalances Innate Immunity to Mitigate Alzheimer-Like Pathology. Neuron 85, 534-548, doi: http://dx.doi.org/10.1016/j.neuron.2014.12.068 (2015).
47. Cardona, A. E. et al. Control of microglial neurotoxicity by the fractalkine receptor. Nature neuroscience 9, 917-924, doi: http://www.nature.com/neuro/journal/v9/n7/suppinfo/nn1715-S1.html (2006).
48. Hsieh, C. L. et al. A role for TREM2 ligands in the phagocytosis of apoptotic neuronal cells by microglia. Journal of Neurochemistry 109, 1144-1156, doi: 10.1111/j.1471-4159.2009.06042.x (2009).
49. Esser, N., Legrand-Poels, S., Piette, J., Scheen, A. J. & Paquot, N. Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes. Diabetes Research and Clinical Practice 105, 141-150, doi: http://dx.doi.org/10.1016/j.diabres.2014.04.006 (2014).
50. Fakhouri, T. H. & Statistics, N. C. f. H. Prevalence of obesity among older adults in the United States, 2007-2010. (Citeseer, 2012).
51. Norton, S., Matthews, F. E., Barnes, D. E., Yaffe, K. & Brayne, C. Potential for primary prevention of Alzheimer's disease: an analysis of population-based data. The Lancet Neurology 13, 788-794, doi: 10.1016/s1474-4422(14)70136-x (2014).
52. Cornelis, M. C. et al. Obesity susceptibility loci and uncontrolled eating, emotional eating and cognitive restraint behaviors in men and women. Obesity 22, E135-E141 (2014).
53. Comuzzie, A. G. & Allison, D. B. The search for human obesity genes. Science 280, 1374-1377 (1998).
54. Lopes da Silva, S. et al. Plasma nutrient status of patients with Alzheimer's disease: Systematic review and meta-analysis. Alzheimer's & Dementia 10, 485-502, doi: http://dx.doi.org/10.1016/j.jalz.2013.05.1771 (2014).
55. Kanoski, S. E. & Davidson, T. L. Western diet consumption and cognitive impairment: links to hippocampal dysfunction and obesity. Physiology & behavior 103, 59-68 (2011).
56. James, M. J., Gibson, R. A. & Cleland, L. G. Dietary polyunsaturated fatty acids and inflammatory mediator production. The American Journal of Clinical Nutrition 71, 343s-348s (2000).
57. Valdearcos, M. et al. Microglia Dictate the Impact of Saturated Fat Consumption on Hypothalamic Inflammation and Neuronal Function. Cell Reports 9, 2124-2138, doi: 10.1016/j.celrep.2014.11.018.
58. Myles, I. A. Fast food fever: reviewing the impacts of the Western diet on immunity. Nutrition journal 13, 61 (2014).
59. Brochard, V. et al. Infiltration of CD4+ lymphocytes into the brain contributes to neurodegeneration in a mouse model of Parkinson disease. The Journal of clinical investigation 119, 182 (2009).
60. Yamasaki, R. et al. Differential roles of microglia and monocytes in the inflamed central nervous system. The Journal of experimental medicine 211, 1533-1549 (2014).
61. Shaftel, S. S. et al. Chronic Interleukin-1β Expression in Mouse Brain Leads to Leukocyte Infiltration and Neutrophil-Independent Blood-Brain Barrier Permeability without Overt Neurodegeneration. The Journal of Neuroscience 27, 9301-9309, doi: 10.1523/jneurosci.1418-07.2007 (2007).
62. Ownby, R. Neuroinflammation and Cognitive Aging. Curr Psychiatry Rep 12, 39-45, doi: 10.1007/s11920-009-0082-1 (2010).
63. Guerreiro, R. et al. TREM2 variants in Alzheimer's disease. New England Journal of Medicine 368, 117-127 (2013).
64. Ulrich, J. D. et al. Altered microglial response to Abeta plaques in APPPS1-21 mice heterozygous for TREM2. Mol Neurodegener 9, 20 (2014).